We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
ELOX
401
Eloxx Pharmaceuticals
ELOX
$59.9M
$59.9M $17.43 31.1%
PMVP icon
402
PMV Pharmaceuticals
PMVP
$59.2M
$59.2M $1.11 1.77%
IMMP
403
Immutep
IMMP
$56.3M
$56.3M $0.3820 0.58%
BOLD
404
Boundless Bio
BOLD
$56.2M
$56.2M $2.50 0%
INO icon
405
Inovio Pharmaceuticals
INO
$55.7M
$55.7M $0.6770 3.2%
DWTX
406
Dogwood Therapeutics
DWTX
$55.2M
$55.2M $1.64 3.8%
CNTX icon
407
Context Therapeutics
CNTX
$55.1M
$55.1M $0.5994 1.3%
MREO
408
Mereo BioPharma
MREO
$54.7M
$54.7M $0.3427 8.79%
INKT icon
409
MiNK Therapeutics
INKT
$52.3M
$52.3M $10.50 0.85%
EDSA icon
410
Edesa Biotech
EDSA
$49.2M
$49.2M $5.11 2.67%
FLNA
411
Filana Therapeutics
FLNA
$48.8M
$48.8M $1.01 5.21%
TCRX icon
412
TScan Therapeutics
TCRX
$48.6M
$48.6M $0.7430 1.68%
TIL icon
413
Instil Bio
TIL
$48.3M
$48.3M $7.12 0.28%
ATYR
414
aTyr Pharma
ATYR
$47.6M
$47.6M $0.4857 1.19%
BYSI icon
415
BeyondSpring
BYSI
$47.3M
$47.3M $1.15 1.77%
MCRB icon
416
Seres Therapeutics
MCRB
$46.8M
$46.8M $4.83 1.05%
INMB icon
417
INmune Bio
INMB
$46.5M
$46.5M $1.75 1.13%
MGX icon
418
Metagenomi Therapeutics
MGX
$44.8M
$44.8M $1.19 2.46%
KPTI icon
419
Karyopharm Therapeutics
KPTI
$43.5M
$43.5M $1.92 72.6%
RNXT icon
420
RenovoRx
RNXT
$43.2M
$43.2M $0.9583 1.82%
EXOZ
421
eXoZymes Inc
EXOZ
$43.2M
$43.2M $4.65 1.09%
HYPD
422
Hyperion DeFi Inc
HYPD
$40M
$40M $2.64 0.75%
PDSB icon
423
PDS Biotechnology
PDSB
$38.4M
$38.4M $0.6861 1.85%
DYAI icon
424
Dyadic International
DYAI
$38.3M
$38.3M $1.05 1.87%
APLM icon
425
Apollomics
APLM
$37.9M
$37.9M $17.25 0.58%
15 16
17
18 19

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.2T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $121B, Regeneron Pharmaceuticals (REGN) at $78.5B and argenx (ARGX) at $53.4B.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.